493019-22-0

Upstream product

• 98-88-4 benzoyl chloride 
• 493019-21-9 Acetic acid (2R,3S,4R,5R,6R)-3-acetoxy-2-acetoxymethyl-5-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-6-[(2R,3S,4R,5R,6S)-5-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-3,4-dihydroxy-6-(4-methoxy-phenoxy)-tetrahydro-pyran-2-ylmethoxy]-tetrahydro-pyran-4-yl ester 
• 395072-12-5 p-methoxyphenyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 138906-42-0 p-Methoxyphenyl 2-deoxy-2-phthalimido-β-D-glucopyranoside 

Downstream Products

• 493019-24-2 C₄₉H₄₂N₂O₁₆ 

Relevant academic research and scientific papers

8-(Methyltosylaminoethynyl)-1-naphthyl (MTAEN) Glycosides: Potent Donors in Glycosides Synthesis

With 8-(methyltosylaminoethynyl)-1-naphthyl (MTAEN) glycoside as donors, a novel and efficient glycosylation protocol has been established. The MTAEN glycosylation protocol exhibits the merits of shelf-stable donors, mild catalytic promotion conditions, considerably extended substrate scope encompassing both free alcohols, silylated alcohols, nucleobases, primary amides, and C-type nucleophile acceptors, and applicability to various one-pot strategies for highly efficient synthesis of oligosaccharides, such as orthogonal one-pot, single-catalyst one-pot, and acceptor reactivity-controlled one-pot strategies.

Synthesis of (1→6)-β-D-glucosamine hexasaccharide, a potential antitumor and immunostimulating agent

(1→6)-β-D-Glucosamine hexasaccharide was synthesized convergently using isopropyl thioglycosides as glycosyl donors in all coupling steps. The target compound showed good antitumor activity based on mice S180 model studies.